Titan Pharmaceuticals (NASDAQ:TTNP) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Price Performance TTNP stock opened at $6.96 on Friday. Titan Pharmaceuticals has a 12 month low of $5.00 and […]

Related Keywords

United States ,Canada , ,Titan Pharmaceuticals Company Profile ,Virtu Financial ,Titan Pharmaceuticals Price Performance ,Titan Pharmaceuticals Inc ,Institutional Investors Weigh In On Titan Pharmaceuticals ,Titan Pharmaceuticals ,Renaissance Technologies ,Millennium Management ,European Union ,News Ratings For Titan Pharmaceuticals Daily ,Free Report ,Street Corp ,Get Free Report ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,